expand_moreexpand_lessexpand_moreexpand_less
|
 |
Amy FeldmanForbes |
Even before it gets approval for its sleep apnea pill, Apnimed is testing investor appetite. The Cambridge, Mass.-based biotech priced its shares at...
In this week’s edition of InnovationRx, we look at Fortell’s efforts to make a better hearing aid, Abby Care’s business getting payment for...
In this week’s edition of InnovationRx, we look at the havoc of generic drug tariffs, the companies looking to cash in on the coming peptide...
When the FDA panel that’s considering whether to recommend legal production of seven peptides meets starting Thursday, Shaun Noorian will be at its...
In this week’s edition of InnovationRx, Thyme Care gets new leadership, the intestinal illness spreads, Chai Discovery confirms its $400 million...
In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion...
When OpenAI wants to sell the country’s biggest health systems on its healthcare ambitions, it often brings in one person a hospital CEO won’t...
In this week’s edition of InnovationRx, we look at Axsome’s growing pipeline, HistoSonics innovative cancer treatment, state litigation over...
In this week’s edition of InnovationRx, we look at biotech M&A, the rise of India’s Anthem Biosciences, and more. To get it in your inbox,...
In this week’s edition of InnovationRx, we look at SpaceX’s hopes for healthcare, the AI drug discovery startup Lilly and Pfizer are betting on,...
ast June, when AI drug discovery startup Chai Discovery was just 15 months old, it released a new model that could design antibodies. Nearly 20 pharma...
In this week’s edition of InnovationRx, we look at cancer breakthroughs from the ASCO conference, Clear’s move into healthcare, Harrison.ai’s...
In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 billion valuation, and...
When Benjamine Liu was a young computational biologist working on his doctorate at the University of Oxford, he had some ideas for novel drugs that...
In this week’s edition of InnovationRx, we look at Revolution Medicine’s pancreatic cancer pill, the top self-made healthcare entrepreneurs, the...
In this week’s edition of InnovationRx, we look at Trump’s pharmaceutical tariffs, the first robotic cataract surgeries in humans, the underbelly...
In this week’s edition of InnovationRx, we look at the federal program to use agentic AI against heart failure, the billionaire dentist, Wegovy by...
Martin Varsavsky has trouble keeping track of all the ventures he’s started. There are more than a dozen of them, including a handful that became...
In this week’s edition of InnovationRx, we look at the legal ruling against RFK Jr.’s vaccine agenda, Roche’s big AI drug development bet, an E....
In this week’s edition of InnovationRx, we look at the richest five healthcare billionaires, Lilly’s first big AI success, Science Corp.’s brain...
For the past few months, neurosurgeons at hospitals in Florida, Connecticut and New York have been preparing for a wildly experimental operation...
login
who are we?
contact us
qosheapp
